anti-CD326 humanized mAb (Xencor)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD326 humanized mAb (Xencor)
Drug Alias Nameanti-EpCAM humanized mAb (Xencor)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionEpithelial cell adhesion molecule inhibitors
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXencor Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A